Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TIL Therapy: Facts and Hopes
Tine Monberg, Troels Holz Borch, Inge Marie Svane, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3275-3283
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
Sebastian Klobuch, Tom Seijkens, Ton N. Schumacher, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 173-184
Closed Access | Times Cited: 39
Adoptive T cell therapy for solid tumors: current landscape and future challenges
Víctor Albarrán, María San Román, Javier Pozas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 17
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy
Chin Leng Tan, Katharina A.M. Lindner, Tamara Boschert, et al.
Nature Biotechnology (2024) Vol. 43, Iss. 1, pp. 134-142
Open Access | Times Cited: 16
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Simon Turcotte, Marco Donia, Brian Gastman, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010207-e010207
Open Access | Times Cited: 2
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
Biomarkers for response to TIL therapy: a comprehensive review
Víctor Albarrán, P Martínez, Joachim Stoltenborg Granhøj, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008640-e008640
Open Access | Times Cited: 14
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 14
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Teresa Amaral, Margaret Ottaviano, Ana Arance, et al.
Annals of Oncology (2024) Vol. 36, Iss. 1, pp. 10-30
Closed Access | Times Cited: 12
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies
Deepak Sherpally, Ashish Manne
Cancers (2025) Vol. 17, Iss. 4, pp. 589-589
Open Access | Times Cited: 1
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
Advancements in Melanoma Therapies: From Surgery to Immunotherapy
Neda Shajari, Behzad Baradaran, Mohammad Reza Tohidkia, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1073-1088
Closed Access | Times Cited: 5
Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines
Nawal Amhis, Julie Carignan, Lee‐Hwa Tai
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200825-200825
Open Access | Times Cited: 4
Immunotherapy for colorectal cancer
Bing Yu, Jian Kang, Hong Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Dongdong Sun, Yijie Hu, Xin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113392-113392
Closed Access | Times Cited: 4
Adoptive cell therapies in thoracic malignancies: a comprehensive review
Yago Garitaonaindía, M. Martínez‐Cutillas, Maria Uribarren, et al.
Clinical & Translational Oncology (2025)
Closed Access
Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions
Izuma Nakayama, Kohei Shitara
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 1
Closed Access
Optical-magnetic Imaging for Optimizing Lymphodepletion-TIL Combination Therapy in Breast Cancer
Jiaqian Li, Lishuang Guo, Yuan Feng, et al.
Molecular Imaging and Biology (2025)
Closed Access
Readiness to Implement Novel SACT: Tumor-Infiltrating Lymphocyte Therapy
Linda Gomm
Seminars in Oncology Nursing (2025), pp. 151841-151841
Closed Access
Highlighting recent achievements to advance more effective cancer immunotherapy
Beatrice Belmonte, Sheila Spada, Paola Allavena, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The paths toward immunotherapy of esophageal cancer: An overview of clinical trials
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions
Liqin Ruan, Lu Wang
Frontiers in Oncology (2025) Vol. 15
Open Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
A multi-omics analysis of effector and resting treg cells in pan-cancer
Anna-Maria Chalepaki, Marios Gkoris, Irene Chondrou, et al.
Computers in Biology and Medicine (2025) Vol. 189, pp. 110021-110021
Closed Access
Page 1 - Next Page

Scroll to top